RT Journal Article
SR Electronic
T1 Bayesian network approach to develop generalisable predictive model for COVID-19 vaccine uptake
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.31.23285300
DO 10.1101/2023.01.31.23285300
A1 Awasthi, Raghav
A1 Nagori, Aditya
A1 Nasri, Bouchra
YR 2023
UL http://medrxiv.org/content/early/2023/10/09/2023.01.31.23285300.abstract
AB The effectiveness of a vaccine depends on vaccine uptake, which is influenced by various factors, including vaccine hesitancy. Vaccine hesitancy is a complex socio-behavioral issue, influenced by misinformation, distrust in healthcare providers and government organizations, fear of side effects, and cultural or religious beliefs. To address this problem, AI models have been developed, but their global generalizability remains unclear. Therefore, this study aimed to identify global determinants of vaccine uptake and develop a generalizable machine learning model to predict individual-level vaccine uptake. The study used publicly available survey data from 23 countries and employed Bayesian networks and generalized mixed effects models to identify key determinants of vaccine uptake. The results showed that trust in the central government and vaccination restrictions for national and international travel were key determinants of vaccine uptake. A generalized mixed effects model achieved an AUC of 89% (SD=1%), precision of 90% (SD = 4%), and recall of 82% (SD=2%) on unseen testing data from new countries, demonstrating the model’s generalizability. The findings of this study can inform targeted interventions to improve vaccine uptake globally.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes